2Hochberb MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosis. Arthritis Rheum, 1997,40 : 1725-1727.
3American Thoracic Society (ATS). Idiopathic Pulmonary Fibrosis: Diagnosis and Treadment. Am J Respir Crit Care Med,2000,161:646-664.
2[1]Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis[J].Arthritis Rheum,1980,23∶581-586.
3[2]Medsger TA.Systemic sclerosis and localized scleroderma.In: Schumacher HR,eds. Primer on the rheumatic diseases[M].Athlanta: Arthritis Fundation,1988.111-128.
4[3]Chappell LT,Janson M.EDTA chelation therapy in the treatment of vascular disease[J].J Cardiovasc Nurs,1996,10(3)∶78-86.
6Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore), 1993, 72:113-124.
7Arakama H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis:serial high-resolution CT findings and functional correlation. Chest,2003, 123:1096-1103.
8Hochberb MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40:1725.
9Hawker G, Gabriel S, Bombardier C, et al. A reliability study of SLEDAI:a disease activity index for systemic lupus erythematosus.J Rheumatol, 1993, 20:657-660.
10Mohammed YK, Luis CM, Colin MT, et al. Presentation prognosis of the shrinking lung syndrome in systemic lupus erythematosus.Semin Arthritis Rheum, 2002, 31: 289-298.
